Lillia Secures $1.7 Million Grant from Qatar Research and Innovation Council
- $1.7 million grant awarded by Qatar Research, Development, and Innovation (QRDI) Council.
- Plans for expansion in the Middle East, North Africa, and Southeast Asia.
- AI-powered health platform focusing on chronic disease management through digital twin technology.
Lillia, a Qatar-based healthtech company specializing in AI-driven healthcare solutions, has received a $1.7 million grant from the Qatar Research, Development, and Innovation (QRDI) Council.
The funding will support the development of a digital twin technology for chronic conditions, enhancing real-time monitoring and predictive capabilities to improve healthcare outcomes.
Founded in 2020 by Sujit Chakrabarti, Lillia was formed through the 2024 merger of Qatar’s Droobi Health and India’s Smit.fit. The company provides an AI-powered platform designed for healthcare providers, insurance companies, enterprises, and the public sector to effectively manage chronic diseases.
Lillia’s AI system combines predictive analytics with expert-led interventions, including psychologists, nutritionists, and medical professionals, creating personalized care plans tailored to individual lifestyles. Since its inception, the company has supported over 40,000 individuals across the Gulf region and India in managing diabetes and weight-related conditions, according to the company’s press statement.
